We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

174 hedge funds and large institutions have $1.86B invested in Celldex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 48 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $24.9M | Put options by funds: $17.1M

38% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 48

2.75% more ownership

Funds ownership: 108.33% → 111.07% (+2.7%)

6% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 36

1% less funds holding

Funds holding: 176 → 174 (-2)

24% less capital invested

Capital invested by funds: $2.44B → $1.86B (-$579M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
174
Holders Change
-2
Holders Change %
-1.14%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
66
Reduced
48
Closed
36
Calls
$24.9M
Puts
$17.1M
Net Calls
+$7.83M
Net Calls Change
-$17.5M

Top Buyers

1
JFG
Jefferies Financial Group
New York
+$64.4M
2
KCM
Kynam Capital Management
New Jersey
+$43.6M
3
DTC
Deep Track Capital
Connecticut
+$41.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$25.7M
5
Morgan Stanley
Morgan Stanley
New York
+$24.7M

Top Sellers

1
CC
Commodore Capital
New York
-$55M
2
Jennison Associates
Jennison Associates
New York
-$45M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.7M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.4M
5
LGM
Logos Global Management
California
-$30.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
126
HSBC Holdings
United Kingdom
$233K +$252K +9,292 New
Victory Capital Management
127
Victory Capital Management
Texas
$202K -$3.99K -147 -2%
AC
128
Aristides Capital
Kentucky
$202K +$217K +8,000 New
Public Employees Retirement Association of Colorado
129
Public Employees Retirement Association of Colorado
Colorado
$197K – – –
CM
130
Caption Management
Oklahoma
$189K -$2.79M -102,538 -93%
AIP
131
Ameritas Investment Partners
Nebraska
$165K – – –
Canada Life
132
Canada Life
Manitoba, Canada
$160K – – –
ACM
133
Aquatic Capital Management
Illinois
$121K +$130K +4,780 New
A
134
AlphaQuest
New York
$108K +$73.5K +2,705 +171%
KBC Group
135
KBC Group
Belgium
$94K +$44.7K +1,647 +79%
HT
136
Headlands Technologies
Illinois
$81.2K +$87.3K +3,212 New
Royal Bank of Canada
137
Royal Bank of Canada
Ontario, Canada
$76K -$128K -4,723 -61%
VEA
138
Virtus ETF Advisers
New York
$67.9K +$4.32K +159 +6%
AB
139
Amalgamated Bank
New York
$55K – – –
Russell Investments Group
140
Russell Investments Group
United Kingdom
$45.6K +$1K +37 +2%
FDCDDQ
141
Federation des caisses Desjardins du Quebec
Quebec, Canada
$39K – – –
EWA
142
EverSource Wealth Advisors
Alabama
$32.5K +$23.9K +878 +216%
RS
143
R Squared
Hong Kong
$22.2K +$23.9K +880 New
BC
144
Bayforest Capital
United Kingdom
$21.9K +$23.5K +865 New
Nisa Investment Advisors
145
Nisa Investment Advisors
Missouri
$13.7K -$3.75K -138 -20%
CIBC Private Wealth Group
146
CIBC Private Wealth Group
Georgia
$13.3K – – –
US Bancorp
147
US Bancorp
Minnesota
$12.9K -$4.7K -173 -25%
Osaic Holdings
148
Osaic Holdings
Arizona
$11.7K -$706 -26 -5%
SCM
149
Sterling Capital Management
North Carolina
$11K +$9.13K +336 +343%
National Bank of Canada
150
National Bank of Canada
Quebec, Canada
$9.63K – – –
4 5
6
7 8

CLDX Hedge Fund Activity: Q4 2024 in Review

174 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q4 2024, worth a combined $1.86B — down 24% from $2.44B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of CLDX and 34 opened new positions — a net loss of 2 holders — while 48 trimmed existing stakes and 66 added.

The largest buyer was Jefferies Financial Group, adding an estimated $64.4M. The largest seller was Commodore Capital, exiting entirely with an estimated $55M sold.

  • 174 institutional investors held Celldex Therapeutics (CLDX) as of Q4 2024, down from 176 in Q3 2024.
  • Funds reported $1.86B of Celldex Therapeutics stock for Q4 2024, down 24% quarter-over-quarter.
  • 34 funds opened new Celldex Therapeutics positions in Q4 2024 and 36 closed out, a net change of -2 holders.
  • The largest Celldex Therapeutics buyer in Q4 2024 was Jefferies Financial Group, an estimated $64.4M added.
  • The largest Celldex Therapeutics seller in Q4 2024 was Commodore Capital, an estimated $55M sold.

Based on aggregated 13F filings for Q4 2024.